News

Medtronic announced the six-month results from the full cohort of the SPYRAL HTN-ON MED clinical trial. The data were presented today as Late-Breaking Clinical Science at the American Heart Association (AHA) Scientific Sessions 2022. 

Medtronic announced that early intervention with its Arctic Front™ Family of Cryoablation Catheters demonstrated superiority over antiarrhythmic drugs (AADs) in preventing atrial arrhythmia recurrence and reducing the rate of atrial...

Findings presented at AHA Scientific Sessions

Compiled Data from RADIANCE Global Program Show Consistent Treatment Effect and Safety Across Broad Patient Population

The first-of-its-kind study included 4000 Ontario paramedics over four years

CARLSBAD, Calif., November 3, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced that the Company has achieved the first...

November 03, 2022 11:18 AM Eastern Daylight Time--SAN CLEMENTE, Calif.--AtaCor Medical, Inc. has announced completion of its second human clinical study of the Extravascular Implantable Cardioverter Defibrillator (EV-ICD) Lead System....

The new Barostim NEO2 Implantable Pulse Generator (IPG) launches in the U.S., improving the patient experience while on therapy and simplifying the implant procedure for physicians

Study Advances Efforts to Launch CARDIALYTICS Suite of Analytic Tools

In collaboration with iRhythm, Tempus is studying its predictive, AI-enabled algorithmic tests via a network of researchers to determine the impact of detecting patients at increased risk of developing cardiovascular disease